Murine gammaherpesvirus 68 encoding open reading frame 11 targets TANK binding kinase 1 to negatively regulate the host type i interferon response

Journal of Virology

Volumn 88, Issue 12, 2014, Pages 6832-6846

  Kang, Hye Ri ^a   Cheong, Woo Chang ^a   Park, Ji Eun ^a   Ryu, Seungbo ^a   Cho, Hye Jeong ^a   Youn, Hyunyee ^a,b   Ahn, Jin Hyun ^c   Songa, Moon Jung ^a  

^a Korea University   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 3; PHOSPHOTRANSFERASE; TANK BINDING KINASE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FIBROBLAST; GAMMAHERPESVIRINAE; IMMUNE RESPONSE; MACROPHAGE; MOUSE; MURINE GAMMAHERPESVIRUS 68; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; DOWN-REGULATION; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-BETA; MICE; OPEN READING FRAMES; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; RHADINOVIRUS; VIRAL PROTEINS;

EID: 84901309628     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03460-13     Document Type: Article

References (67)

1. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. 1997. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 17:5328-5337.
2. Gale M, Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol. Ther. 78:29-46. http://dx.doi.org/10.1016/S0163-7258(97)00165-4.
3. Pellegrini S, John J, Shearer M, Kerr IM, Stark GR. 1989. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway. Mol. Cell. Biol. 9:4605-4612.
4. Symons JA, Alcami A, Smith GL. 1995. Vaccinia virus encodes a soluble type-I interferon receptor of novel structure and broad species-specificity. Cell 81:551-560. http://dx.doi.org/10.1016/0092-8674(95)90076-4.
5. Hwang SY, Hertzog PJ, Holland KA, Sumarsono SH, Tymms MJ, Hamilton JA, Whitty G, Bertoncello I, Kola I. 1995. A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. U. S. A. 92:11284-11288. http://dx.doi.org/10.1073/pnas.92.24.11284.
6. Deonarain R, Alcami A, Alexiou M, Dallman MJ, Gewert DR, Porter AC. 2000. Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J. Virol. 74:3404-3409. http://dx.doi.org/10.1128/JVI.74.7.3404-3409.2000.
7. Gibbert K, Joedicke JJ, Meryk A, Trilling M, Francois S, Duppach J, Kraft A, Lang KS, Dittmer U. 2012. Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection. PLoS Pathog. 8:e1002868. http://dx.doi.org/10.1371/journal.ppat.1002868.
8. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
9. Malmgaard L. 2004. Induction and regulation of IFNs during viral infections. J. Interferon Cytokine Res. 24:439-454. http://dx.doi.org/10.1089/1079990041689665.
10. Hiscott J. 2007. Triggering the innate antiviral response through IRF-3 activation. J. Biol. Chem. 282:15325-15329. http://dx.doi.org/10.1074/jbc.R700002200.
11. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491-496. http://dx.doi.org/10.1038/ni921.
12. Sharma S, ten Oever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
13. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:1641-1650. http://dx.doi.org/10.1084/jem.20040520.
14. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 101:233-238. http://dx.doi.org/10.1073/pnas.2237236100.
15. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, Kamps MP, Raz E, Wagner H, Hacker G, Mann M, Karin M. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204-207. http://dx.doi.org/10.1038/nature04369.
16. Ishii KJ, Kawagoe T, Koyama S, Matsui K, Kumar H, Kawai T, Uematsu S, Takeuchi O, Takeshita F, Coban C, Akira S. 2008. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature 451:725-729. http://dx.doi.org/10.1038/nature06537.
17. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G. 2006. Critical role of TRAF3 in the Toll-like receptordependent and-independent antiviral response. Nature 439:208-211. http://dx.doi.org/10.1038/nature04374.
18. Ryzhakov G, Randow F. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26:3180-3190. http://dx.doi.org/10.1038/sj.emboj.7601743.
19. Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, Seya T. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177:8676-8683. http://www.jimmunol.org/content/177/12/8676.
20. Stetson DB, Medzhitov R. 2006. Recognition of cytosolic DNA activates an IRF3-dependent innate immune response. Immunity 24:93-103. http://dx.doi.org/10.1016/j.immuni.2005.12.003.
21. Chau TL, Gioia R, Gatot JS, Patrascu F, Carpentier I, Chapelle JP, O'Neill L, Beyaert R, Piette J, Chariot A. 2008. Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? Trends Biochem. Sci. 33:171-180. http://dx.doi.org/10.1016/j.tibs.2008.01.002.
22. Guo B, Cheng G. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282:11817-11826. http://dx.doi.org/10.1074/jbc. M700017200.
23. Chen H, Sun H, You F, Sun W, Zhou X, Chen L, Yang J, Wang Y, Tang H, Guan Y, Xia W, Gu J, Ishikawa H, Gutman D, Barber G, Qin Z, Jiang Z. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147:436-446. http://dx.doi.org/10.1016/j.cell.2011.09.022.
24. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. http://dx.doi.org/10.1038/nature07317.
25. Perry A, Chow E, Goodnough J, Yeh W-C, Cheng G. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection. J. Exp. Med. 199:1651-1658. http://dx.doi.org/10.1084/jem.20040528.
26. Miyahira A, Shahangian A, Hwang S, Sun R, Cheng G. 2009. TANKbinding kinase-1 plays an important role during in vitro and in vivo type I IFN responses toDNAvirus infections. J. Immunol. 182:2248-2257. http://dx.doi.org/10.4049/jimmunol.0802466.
27. Moore PS, Chang Y. 2001. Kaposi's sarcoma-associated herpesvirus, p 2803-2833. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed, vol 2. Lippincott Williams and Wilkins, Philadelphia, PA.
28. Rickinson AB, KieffE. 2001. Epstein-Barr virus, p 2575-2628. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 4th ed, vol 2. Lippincott Williams and Wilkins, Philadelphia, PA.
29. Doherty PC, Christensen JP, Belz GT, Stevenson PG, Sangster MY. 2001. Dissecting the host response to a gamma-herpesvirus. Philos. Trans. R. Soc. London Ser. B Biol. Sci. 356:581-593. http://dx.doi.org/10.1098/rstb.2000.0786.
30. Nash AA, Dutia BM, Stewart JP, Davison AJ. 2001. Natural history of murine gamma-herpesvirus infection. Philos. Trans. R. Soc. London Ser. B Biol. 356:569-579. http://dx.doi.org/10.1098/rstb.2000.0779.
31. Speck SH, Virgin HW. 1999. Host and viral genetics of chronic infection: a mouse model of gamma-herpesvirus pathogenesis. Curr. Opin. Microbiol. 2:403-409. http://dx.doi.org/10.1016/S1369-5274(99)80071-X.
32. Virgin HW, Speck SH. 1999. Unraveling immunity to gammaherpesviruses: a new model for understanding the role of immunity in chronic virus infection. Curr. Opin. Immunol. 11:371-379. http://dx.doi.org/10.1016/S0952-7915(99)80063-6.
33. Flaño E, Kim I-J, Woodland D, Blackman M. 2002. Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J. Exp. Med. 196:1363-1372. http://dx.doi.org/10.1084/jem.20020890.
34. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T. 1998. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J. Exp. Med. 187:1941-1951. http://dx.doi.org/10.1084/jem.187.12.1941.
35. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73(Part 9):2347-2356. http://dx.doi.org/10.1099/0022-1317-73-9-2347.
36. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. B cells regulate murine gammaherpesvirus 68 latency. J. Virol. 73:4651-4661.
37. Weck KE, Kim SS, Virgin HW, Speck SH. 1999. Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. J. Virol. 73:3273-3283.
38. Song MJ, Hwang SM, Wong WH, Wu TT, Lee SM, Liao HI, Sun R. 2005. Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 102:3805-3810. http://dx.doi.org/10.1073/pnas.0404521102.
39. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11:143-154. http://dx.doi.org/10.1038/nri2937.
40. Hwang S, Maloney NS, Bruinsma MW, Goel G, Duan E, Zhang L, Shrestha B, Diamond MS, Dani A, Sosnovtsev SV, Green KY, Lopez-Otin C, Xavier RJ, Thackray LB, Virgin HW. 2012. Nondegradative role of Atg5-Atg12/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11:397-409. http://dx.doi.org/10.1016/j.chom.2012.03.002.
41. Smith GA, Enquist LW. 1999. Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J. Virol. 73:6405-6414.
42. Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R. 2000. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J. Virol. 74:3659-3667. http://dx.doi.org/10.1128/JVI.74.8.3659-3667.2000.
43. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step Red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40:191-197. http://dx.doi.org/10.2144/000112096.
44. Hwang SM, Kim KS, Flano E, Wu TT, Tong LM, Park AN, Song MJ, Sanchez DJ, O'Connell RM, Cheng GH, Sun R. 2009. Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response. Cell Host. Microbe 5:166-178. http://dx.doi.org/10.1016/j.chom.2008.12.013.
45. Ahn JW, Powell KL, Kellam P, Alber DG. 2002. Gammaherpesvirus lytic gene expression as characterized by DNA array. J. Virol. 76:6244-6256. http://dx.doi.org/10.1128/JVI.76.12.6244-6256.2002.
46. Ebrahimi B, Dutia BM, Roberts KL, Garcia-Ramirez JJ, Dickinson P, Stewart JP, Ghazal P, Roy DJ, Nash AA. 2003. Transcriptome profile of murine gammaherpesvirus-68 lytic infection. J. Gen. Virol. 84:99-109. http://dx.doi.org/10.1099/vir.0.18639-0.
47. Martinez-Guzman D, Rickabaugh T, Wu TT, Brown H, Cole S, Song MJ, Tong LM, Sun R. 2003. Transcription program of murine gammaherpesvirus 68. J. Virol. 77:10488-10503. http://dx.doi.org/10.1128/JVI.77.19.10488-10503.2003.
48. Boname JM, May JS, Stevenson PG. 2005. Murine gammaherpesvirus 68 open reading frame 11 encodes a nonessential virion component. J. Virol. 79:3163-3168. http://dx.doi.org/10.1128/JVI.79.5.3163-3168.2005.
49. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Sousa CRE, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
50. Davison AJ, Stow ND. 2005. New genes from old: redeployment of dUTPase by herpesviruses. J. Virol. 79:12880-12892. http://dx.doi.org/10.1128/JVI.79.20.12880-12892.2005.
51. Persson R, McGeehan J, Wilson KS. 2005. Cloning, expression, purification, and characterisation of the dUTPase encoded by the integrated Bacillus subtilis temperate bacteriophage SPbeta. Protein Expr. Purif. 42: 92-99. http://dx.doi.org/10.1016/j.pep.2005.02.013.
52. Ikeda F, Hecker CM, Rozenknop A, Nordmeier RD, Rogov V, Hofmann K, Akira S, Dotsch V, Dikic I. 2007. Involvement of the ubiquitinlike domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J. 26:3451-3462. http://dx.doi.org/10.1038/sj.emboj.7601773.
53. Tu D, Zhu Z, Zhou AY, Yun CH, Lee KE, Toms AV, Li Y, Dunn GP, Chan E, Thai T, Yang S, Ficarro SB, Marto JA, Jeon H, Hahn WC, Barbie DA, Eck MJ. 2013. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Rep. 3:747-758. http://dx.doi.org/10.1016/j.celrep.2013.01.033.
54. Larabi A, Devos JM, Ng SL, Nanao MH, Round A, Maniatis T, Panne D. 2013. Crystal structure and mechanism of activation of TANK-binding kinase 1. Cell Rep. 3:734-746. http://dx.doi.org/10.1016/j.celrep.2013.01.034.
55. Helgason E, Phung QT, Dueber EC. 2013. Recent insights into the complexity of Tank-binding kinase 1 signaling networks: the emerging role of cellular localization in the activation and substrate specificity of TBK1. FEBS Lett. 587:1230-1237. http://dx.doi.org/10.1016/j.febslet.2013.01.059.
56. Zhao W. 2013. Negative regulation of TBK1-mediated antiviral immunity. FEBS Lett. 587:542-548. http://dx.doi.org/10.1016/j.febslet.2013.01.052.
57. Otsuka M, Kato N, Moriyama M, Taniguchi H, Wang Y, Dharel N, Kawabe T, Omata M. 2005. Interaction between the HCV NS3 protein and the hostTBK1protein leads to inhibition of cellular antiviral responses. Hepatology 41:1004-1012. http://dx.doi.org/10.1002/hep.20666.
58. Verpooten D, Feng Z, Valyi-Nagy T, Ma Y, Jin H, Yan Z, Zhang C, Cao Y, He B. 2009. Dephosphorylation of eIF2alpha mediated by the gamma134.5 protein of herpes simplex virus 1 facilitates viral neuroinvasion. J. Virol. 83:12626-12630. http://dx.doi.org/10.1128/JVI.01431-09.
59. Ma Y, Jin H, Valyi-Nagy T, Cao Y, Yan Z, He B. 2012. Inhibition of TANK binding kinase 1 by herpes simplex virus 1 facilitates productive infection. J. Virol. 86:2188-2196. http://dx.doi.org/10.1128/JVI.05376-11.
60. Tenoever BR, Ng SL, Chua MA, McWhirter SM, Garcia-Sastre A, Maniatis T. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315:1274-1278. http://dx.doi.org/10.1126/science.1136567.
61. Ng MH, Ho TH, Kok KH, Siu KL, Li J, Jin DY. 2011. MIP-T3 is a negative regulator of innate type I IFN response. J. Immunol. 187:6473-6482. http://dx.doi.org/10.4049/jimmunol.1100719.
62. Clement JF, Meloche S, Servant MJ. 2008. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 18:889-899. http://dx.doi.org/10.1038/cr.2008.273.
63. Wu L, Fossum E, Joo CH, Inn KS, Shin YC, Johannsen E, Hutt-Fletcher LM, Hass J, Jung JU. 2009. Epstein-Barr virus LF2: an antagonist to type I interferon. J. Virol. 83:1140-1146. http://dx.doi.org/10.1128/JVI.00602-08.
64. Leang RS, Wu TT, Hwang SM, Liang LT, Tong LM, Truong JT, Sun R. 2011. The anti-interferon activity of conserved viral dUTPase ORF54 is essential for an effective MHV-68 infection. PLoS Pathog. 7:e1002292. http://dx.doi.org/10.1371/journal.ppat.1002292.
65. Bisson SA, Page AL, Ganem D. 2009. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferonmediated signal transduction. J. Virol. 83:5056-5066. http://dx.doi.org/10.1128/JVI.02516-08.
66. Madrid AS, Ganem D. 2012. Kaposi's sarcoma-associated herpesvirus ORF54/dUTPase downregulates a ligand for the NK activating receptor NKp44. J. Virol. 86:8693-8704. http://dx.doi.org/10.1128/JVI.00252-12.
67. Barton ES, Lutzke ML, Rochford R, Virgin HW. 2005. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency. J. Virol. 79:14149-14160. http://dx.doi.org/10.1128/JVI.79.22.14149-14160.2005.